References
Products Transfection
Free Sample Offer
Instruction for Use:
In the „Transfection Reagent Selection Guide“ you can find existing references by setting different filters e.g. for your combination of nucleic acid and cell type. Appropriate keywords in the “Search references“ at the top of the page can also yield a result. A reference indicates that the found transfection reagent has been successfully used for the corresponding application. Ideally, tested transfection parameters and transfection efficiencies are specified.
No reference? > General Selection Guide
If the list does not include a reference concerning your cell type, this does not mean that there is no suitable reagent available, but only that there is no report of experiences with this cell type. In this case it is necessary to preselect (General Selection Guide) and test a reagent (Free Sample Offer). If you want to write an application note for us we will make you an Offer for consideration.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
143B |
Human osteosarcoma cell line | ATCC CRL-8303 | Human | bone | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | V. R. Lo Vasco et al., Anticancer Res, Aug 2014; 34: 4069 - 4075 | ||
143B |
Human osteosarcoma cell line | ATCC CRL-8303 | Human | bone | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | V. R. L. Vasco et al., J. Cell Commun. Signal, 2014, 8:219-229, DOI 10.1007/s12079-014-0235-9 | Link | |
143B |
Human osteosarcoma cell line | ATCC CRL-8303 | Human | bone | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | V. R. Lo Vasco et al., J. Cell Commun. Signal., 2015, 9:55-62; DOI 10.1007/s12079-015-0265-y | ||
143B |
Human osteosarcoma cell line | ATCC CRL-8303 | Human | bone | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | M. Leopizzi., PhD Thesis, 2018, University of Rome | Link | |
293A |
Human embryonic kidney adenovirus producer cell line (derivat of HEK293) | DSM ACC 305 | Human | urinary system | cell line | adherent | sgRNA | CRISPR | Metafectene SI | publication | K. Kang et al., J. of Animal Sci. and Biotech., 2019, doi.org/10.1186/s40104-019-0354-510: 43 | Link | |
293A |
Human embryonic kidney adenovirus producer cell line (derivat of HEK293) | Human | urinary system | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | A. D. Konitsiotis et al., PLoS ONE, 2014, 9(3): e89899, doi:10.1371/journal.pone.0089899 | Link | ||
293T |
Human embryonic kidney cell line, SV40 large T antigen inserted | ATCC CRL-3216 | Human | urinary system | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | Z. Mbita et al., Mol. Cell. Biochem., 2012, 362: 249–262, DOI 10.1007/s11010-011-1150-5 | ||
5637 |
Human urinary bladder grade II carcinome cell line | ATCC HTB-9 | Human | urinary system | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | C. Amantini et al., Oncotarget, 2016, 7(31): 50180-50194 | Link | |
A-2058 |
Human skin melanoma cell line | ATCC CRL-11147 | Human | skin | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | F. Albano et al., Biochimie, 2012, DOI: 10.1016/j.biochi.2012.12.012 | ||
A549 |
Human lung alveolar epithelial adenocarcinoma carcinoma cell line | ATCC CCL-185 | Human | respiratory system | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | A. D. Konitsiotis et al., PLoS ONE, 2014, 9(3): e89899, doi:10.1371/journal.pone.0089899 | Link | |
A818-1 |
Human pancreatic ductal adenocarcinoma cell line | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | A. D. Konitsiotis et al., PLoS ONE, 2014, 9(3): e89899, doi:10.1371/journal.pone.0089899 | Link | ||
BON |
pancreatic neuroendocrine tumor cell line | Human | unknown | cell line | siRNA | high troughput application | Metafectene SI | publication | X. Zhang et al., J. Cell Biol., 2017, doi.org/10.1083/jcb.201702099 | Link | |||
BON |
Human pancreatic neuroendocrine tumor cell line | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | E. Crummy et al., J. Biol. Chem., 2019, doi/10.1074/jbc.RA119.007504 | Link | ||
BON |
Human pancreatic neuroendocrine tumor cell line | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | X. A. Zhang et al., Bio Protoc., 2018, 8 (1): doi:10.21769/BioProtoc.2680 | Link | ||
BON |
pancreatic neuroendocrine tumor cell line | Human | unknown | cell line | siRNA | Metafectene SI | publication | X. Zhang et al., J. Cell Biol., 2017, doi.org/10.1083/jcb.201702099 | Link | ||||
C2C12 |
Mouse myoblast cell line | ATCC CRL-1772 | Mouse | muscle | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | M. Hatem-Vaquero et al., J. Endocrinol., May 2017, doi: 10.1530/JOE-16-0662 | ||
CHO-K1 |
Chinese hamster ovary cell line | ATCC CCL-61 | Hamster | genital tract | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | D. A. Eisinger et al., Mol. Pharmacol., Feb 2011; 79: 326 - 335 | Link | |
HCT-116 |
Human colon adenocarcinoma cell line | ATCC CCL-247 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | N. Golob-Schwarzl et al., Oncotarget, 2017, 8(60): 101224-101243 | Link | |
HCT116 |
Human colon adenocarcinoma cell line | ATCC CCL-247 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | Q. Zhang et al., eLife Sci, Jan 2014; 3: e03077 | Link | |
HCT116 |
Human colon adenocarcinoma cell line | ATCC CCL-247 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | X. Zhou et al., Cell Death and Differentiation, 2015, 22:755-766; doi:10.1038/cdd.2014.167 | Link | |
HCT116 |
Human colon adenocarcinoma cell line | ATCC CCL-247 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | O. D. K. Maddocks et al., Natur, 2013, 542 (493), doi:10.1038/nature11743 | ||
HCT116 |
Human colon carcinoma cell line | ATCC CCL-247 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | S. Belluti et al., Cell Death and Disease (2013) 4, e756; doi:10.1038/cddis.2013.287 | ||
HCT116 p53 -/- |
Human colon adenocarcinoma cell line deficient of p53 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | X. Zhou et al., J. Biol. Chem., Jul 2013; 288: 21793 - 21801 | Link | ||
HEK/DOR |
Human embryonic kidney cell line stably expressing DOR (derivat of HEK293) | Human | urinary system | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | D. A. Eisinger et al., Mol. Pharmacol., Feb 2011; 79: 326 - 335 | Link | ||
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | S. M. Usmani et al., Cell. Microbiology, 2012, 14(3): 299–315, doi:10.1111/j.1462-5822.2011.01724.x | Link |